Clera home
·Dashboard

Jobs at Bicara Therapeutics (Now Hiring) — 9 open

Bicara Therapeutics logoBicara Therapeutics

Director, Medical Affairs Operations

United States · Hybrid

$223k–$259k/yr

Senior+$463M raised

Position Overview Bicara Therapeutics is seeking a Director, Medical Affairs Operations who will support the strategic direction and oversee the tactical execution of operations for the Medical Affairs department. This w…

Skills: Program Management, Medical Affairs Operations, Budget Management, Vendor Management, Cross-functional Leadership

Bicara Therapeutics logoBicara Therapeutics

Senior Manager, Accounting and SEC Reporting

Boston, Massachusetts, United States · Hybrid

$167k–$202k/yr

Senior+$463M raised

Position Overview Bicara Therapeutics is seeking a proactive and detailed-oriented Senior Manager, Accounting and SEC Reporting, to join our growing Accounting Team. This individual will report to the Senior Director, Ac…

Skills: SEC Reporting, US GAAP, Financial Statement Preparation, Stock-Based Compensation, Account Reconciliation

Bicara Therapeutics logoBicara Therapeutics

Director, HCP Marketing

Boston, Massachusetts, United States · Hybrid

$231k–$269k/yr

Senior+$463M raised

Position Overview Bicara Therapeutics is seeking a Director, Healthcare Professional Marketing (HCP) Lead to develop, lead, and execute HCP marketing strategy and promotions for Bicara’s lead candidate, Ficerafusp Alfa. …

Skills: HCP Marketing Strategy, Product Launch, Oncology Business Acumen, Omnichannel Marketing, Brand Planning

Bicara Therapeutics logoBicara Therapeutics

Associate Director, Global Scientific Communications

Boston, Massachusetts, United States · Hybrid

$199k–$236k/yr

Senior$463M raised

Position Overview Bicara Therapeutics is seeking an Associate Director, Global Scientific Communications, who will lead the development and execution of global scientific communication plans across key assets. This role …

Skills: Scientific Communication Planning, Publication Management, Medical Writing, Cross-Functional Leadership, Vendor Management

Bicara Therapeutics logoBicara Therapeutics

Sr. Quality Specialist, GxP Document Control

Boston, Massachusetts, United States · Hybrid

$105k–$128k/yr

Senior$463M raised

Position Overview Bicara Therapeutics is seeking a Senior QA Specialist, GxP Document Control and Quality Systems to support the administration, organization, and continuous improvement of the Quality Management System (…

Skills: Document Control, Quality Management Systems, GxP Compliance, Audit Scheduling, CAPA Management

Bicara Therapeutics logoBicara Therapeutics

Vice President, Quality

Boston, Massachusetts, United States · Hybrid

$315k–$371k/yr

Senior+$463M raised

Position Overview Bicara Therapeutics is seeking a Vice President, Quality to serve as a key member of the leadership team, playing a critical role in shaping the company's long-term success, regulatory readiness, and op…

Skills: Quality Strategy, GCP, GMP, Regulatory Compliance, CMO Oversight

Bicara Therapeutics logoBicara Therapeutics

Senior Medical Science Liaison (multiple territories)

United States · Remote OK

$242k–$289k/yr

Senior$463M raised

Position Overview Bicara Therapeutics is seeking a Senior Medical Science Liaison (MSL) to serve as the field-based medical and scientific expert for the company, focusing on engagement with healthcare providers to provi…

Skills: Medical Science Liaison, KOL Engagement, Clinical Research, Oncology, Scientific Communication

Bicara Therapeutics logoBicara Therapeutics

Senior Clinical Trial Manager (Global)

Boston, Massachusetts, United States · Hybrid

$179k–$211k/yr

Senior$463M raised

Position Overview Bicara Therapeutics is seeking a Senior Clinical Trial Manager (Global) to oversee multiple regions and help lead the operational execution required to bring our science to patients. In this role, you w…

Skills: Clinical Trial Management, Vendor Oversight, CRO Management, Risk Management, Global Trial Execution

Bicara Therapeutics logoBicara Therapeutics

Vice President, Market Access

Boston, Massachusetts, United States · Hybrid

$341k–$394k/yr

Senior+$463M raised

Position Overview Bicara Therapeutics is seeking a strategic, innovative, and execution-focused Vice President, Market Access to build and lead the company’s global market access organization in preparation for the poten…

Skills: Market Access Strategy, Payer Engagement, Pricing Strategy, Reimbursement, Trade And Distribution

Bicara Therapeutics logo

Director, Medical Affairs Operations

Bicara Therapeutics

United States • Hybrid

Apply
Senior+Hybrid · 3 days in office

Tired of cold applications?

Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.

  • $223k–$259k/yr
  • Full-time
  • bachelor degree, postgraduate degree
  • Medical Insurance, Dental Insurance, Vision Insurance, Short Term Incentives, Long Term Incentives, Cash Bonus
  • Posted 1d ago
  • ~40 hrs/week

Responsibilities

Oversee the tactical execution and strategic direction of Medical Affairs operations, including budget management, vendor onboarding, and project tracking. Lead cross-functional workstreams for IST operations, medical education grants, and the development of SOPs and dashboards.

Requirements

Requires a bachelor's degree in a health-related field (advanced degree preferred) and over 8 years of program management experience in the biotech or pharmaceutical industry. Candidates should have proven leadership skills, launch experience, and the ability to travel up to 20%.

Full job description

Position Overview

Bicara Therapeutics is seeking a Director, Medical Affairs Operations who will support the strategic direction and oversee the tactical execution of operations for the Medical Affairs department. This will include the development and execution of strategic plans, oversight of contracting activities, creation of dashboards and managing multiple projects concomitantly. This position will work cross-functionally with other leaders and functions (including all Medical Affairs functions, Commercial, Compliance, IT, Finance, Clinical Development and Legal) to drive from inception to completion all Medical Affairs workstreams and projects and to provide relevant medical input on the strategic and tactical support. The ability to work with and influence stakeholders across all levels will be essential.

This role is based in our Boston office and follows a hybrid schedule, with three in-office days each week.

For an exceptional candidate, the level of this role may be adjusted commensurate with experience and qualifications.

Responsibilities

  • Operationalize annual medical affairs strategic plan and provide operational support for medical affairs programs, including but not limited to managing vendor onboarding process, purchase order generation for new/existing vendors and agencies, tracking and forecasting as necessary.

  • Lead IST Operations including tracking budget, drug material planning and forecasting with supply chain.

  • Routinely and consistently track IST study timelines and all publications (planned & actual). Ensure draft publications are processed through review and timely feedback provided to investigators.

  • Lead the Medical Education Grants and Sponsorship activities within medical affairs with cross functional collaboration. Follow through on process with decisions communicated and follow up as needed for these activities.

  • Work with Medical Affairs leadership to create annual advisory board strategy, manage ad board logistics, contracting, vendor sourcing, working with legal/compliance.

  • Drive budget management in areas of forecasting, annual operating plan and actual accruals. Ensure accurate and up to date budget tracking which feeds into periodic corporate budget reforecasting and annual projections for program budgets.

  • Create and update cross functional launch and project specific dashboards for MA, including slide decks for BoD meetings, dashboard reporting etc.

  • Conduct periodic assessments of Medical Affairs capabilities, processes, and systems to identify gaps and opportunities for improvement. Implement with leadership, platform/ processes to drive efficiencies and provide robust reporting capabilities.

  • Administrator for SharePoint for assigned projects as needed; developing site/folder structure internal review and site content.

  • Responsible for development and maintenance of SOPs for all medical affairs functional groups and activities.

  • Ensure compliance with SOPs across all activities, identification and appropriate escalation of issues/risks and responsible for 100% audit readiness for medical affairs programs.

  • Responsible for maintaining Veeva systems within medical affairs and working cross functionally for appropriate workflows within systems.

  • Collaborate with field medical affairs for CRM reporting activities and create dashboards for leadership view with business operations colleagues.

Qualifications

  • Bachelor’s degree, preferably in a health-related field; advanced degree preferred.

  • 8+ years’ program management experience in biotech or pharmaceutical industry and strong understanding of Medical Affairs function.

  • Launch experience is strongly preferred.

  • Proven leadership skills with demonstrated project management proficiency and a positive approach in managing staff, vendors and project related issues.

  • Must be a team player with strong self-awareness and excellent interpersonal skills.

  • Demonstrated ability to influence others and to successfully lead in a cross-functional environment.

  • Ability to travel up to 20% for conferences and meetings.

Company Overview

Bicara Therapeutics is a clinical-stage biotech company pioneering bifunctional antibodies for targeted tumor modulation. Founded in 2020, we've built a global team of over 100 employees headquartered in Boston, with a clear focus on advancing our lead asset, ficerafusp alfa, or FICERA - a potentially first-in-class bifunctional EGFR-directed antibody combined with a TGF-β ligand trap. Our innovative approach combines tumor-targeting with tumor modulation, where one arm localizes to the tumor while the other serves as a modulator, designed to deliver superior efficacy, improved safety, and enhanced durability directly at the tumor site. FICERA specifically addresses a key challenge in solid tumor treatment by enabling immune cell penetration into tumors, reducing fibrosis and immunosuppression while reversing TGF-β-driven resistance mechanisms - ultimately designed to drive the deep, durable responses that may translate into better outcomes and survival for patients. For more information, please visit www.bicara.com.

Here at Bicara, we believe in building diverse teams and cultivating a culture where all voices are included. We encourage people from all backgrounds to apply.

Bicara Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.

Related keywords

Medical AffairsBiotechPharmaceuticalVeevaSharePointCRMSOPIST OperationsMedical Education GrantsAdvisory BoardsBudget ForecastingClinical DevelopmentComplianceBifunctional AntibodiesTumor ModulationProgram Management

About Bicara Therapeutics

LinkedInVisit site

Pioneering bifunctional antibodies for targeted tumor modulation

Industry
Biotechnology Research
Company size
51-200 employees
Founded
2020
Headquarters
Boston, Massachusetts
LinkedIn followers
19,456
Total funding
$463M

Bicara is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Bicara has built a platform designed to facilitate the development of bifunctional therapies that precisely target the tumor and deliver a tumor-modulating payload to the tumor site. This approach was deployed in the development of Bicara’s lead program ficerafusp alfa, formerly BCA101, a bifunctional epidermal growth factor receptor (EGFR) directed monoclonal antibody bound to a human transforming growth factor beta (TGF-β) ligand trap. By combining these two clinically validated targets, ficerafusp alfa has the potential to exert potent anti-tumor activity by simultaneously blocking both cancer cell-intrinsic EGFR survival and proliferation, as well as the immunosuppressive TGF-β signaling within the tumor microenvironment (TME). Ficerafusp alfa directs the TGF-β inhibitor into the immediate TME through the binding of EGFR on tumor cells, which Bicara believes will lead to deep and durable responses and an increase in overall survival, while reducing the potential adverse effects previously associated with systemic TGF-β inhibition. Ficerafusp alfa is being developed in head and neck squamous cell carcinoma, where there remains a significant unmet need, as well as other solid tumor types. For more information, please visit www.bicara.com

Offices: Boston, Massachusetts, US

ImmunotherapyTargeted Oncologyand Drug DiscoveryHealth CareBiopharmaOncologyBiotechnologyLife ScienceTherapeutics
View all jobs at Bicara Therapeutics

About Bicara Therapeutics

LinkedInVisit site

Pioneering bifunctional antibodies for targeted tumor modulation

Industry
Biotechnology Research
Company size
51-200 employees
Founded
2020
Headquarters
Boston, Massachusetts
LinkedIn followers
19,456
Total funding
$463M

Bicara is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Bicara has built a platform designed to facilitate the development of bifunctional therapies that precisely target the tumor and deliver a tumor-modulating payload to the tumor site. This approach was deployed in the development of Bicara’s lead program ficerafusp alfa, formerly BCA101, a bifunctional epidermal growth factor receptor (EGFR) directed monoclonal antibody bound to a human transforming growth factor beta (TGF-β) ligand trap. By combining these two clinically validated targets, ficerafusp alfa has the potential to exert potent anti-tumor activity by simultaneously blocking both cancer cell-intrinsic EGFR survival and proliferation, as well as the immunosuppressive TGF-β signaling within the tumor microenvironment (TME). Ficerafusp alfa directs the TGF-β inhibitor into the immediate TME through the binding of EGFR on tumor cells, which Bicara believes will lead to deep and durable responses and an increase in overall survival, while reducing the potential adverse effects previously associated with systemic TGF-β inhibition. Ficerafusp alfa is being developed in head and neck squamous cell carcinoma, where there remains a significant unmet need, as well as other solid tumor types. For more information, please visit www.bicara.com

Offices: Boston, Massachusetts, US

ImmunotherapyTargeted Oncologyand Drug DiscoveryHealth CareBiopharmaOncologyBiotechnologyLife ScienceTherapeutics
View all jobs at Bicara Therapeutics

Similar companies hiring

Thermo Fisher Scientific (2302)Roche (1153)CSL (977)Amgen (871)ICON plc (738)Syneos Health (398)Mineralys Therapeutics, Inc. (314)Fortrea (253)Agilent Technologies (242)Gilead Sciences (202)BeiGene (174)Genentech (168)
Clera home

Your AI-talent agent. Connecting talents with dream jobs.

Earn $5,000

Tools

  • Salary Calculator
  • Resume Review
  • Startup Map

Explore

  • Jobs
  • Discover Jobs
  • Companies
  • Referral

Platform

  • Pricing
  • Integrations
  • Partners
  • Acquihire

Clera

  • Manifesto
  • Engineering
  • We are hiring!
  • FAQs
  • Blog
  • Press

Tools

  • Salary Calculator
  • Resume Review
  • Startup Map

Explore

  • Jobs
  • Discover Jobs
  • Companies
  • Referral

Platform

  • Pricing
  • Integrations
  • Partners
  • Acquihire

Clera

  • Manifesto
  • Engineering
  • We are hiring!
  • FAQs
  • Blog
  • Press

© 2026 Clera Labs, Inc.

PrivacyTermsBug Bounty